Let's Talk About Semaglutide and Tirzepatide for Weight Loss | Ep.27

29/07/2025 38 min

Listen "Let's Talk About Semaglutide and Tirzepatide for Weight Loss | Ep.27"

Episode Synopsis

In this no-holds-barred episode of Living Vividly, Jackie Hettitch and Daphne Olivier finally confront the elephant in the room: injectable weight loss medications like Ozempic, Wegovy, Mounjaro, and Zepbound. With a blend of curiosity, caution, and straight talk, they break down what these GLP-1 and GIP agonists actually do, how they affect insulin resistance, blood sugar, and appetite—and what you're not hearing from mainstream providers.From fat loss vs. lean mass loss, GI side effects, and long-term risks, to ethical concerns, societal pressure, and the pharma money machine behind it all—they cover it. Is it a helpful tool or another quick-fix trap? Should it be used in kids? What lifestyle changes matter most?Whether you’re considering these meds or just trying to make sense of the hype, this episode gives you the insight to make informed decisions—no judgment, just real talk.Subscribe for more real conversations on health and wellnessLeave a comment—what’s your take on weight loss injections?

More episodes of the podcast Living Vividly